Silence Therapeutics plc (SLNCF)
OTCMKTS · Delayed Price · Currency is USD
4.000
0.00 (0.00%)
At close: Sep 23, 2026
Silence Therapeutics Market Cap
Silence Therapeutics has a market cap or net worth of $674.34 million as of September 28, 2026. Its market cap has increased by 177.76% in one year.
Market Cap
674.34M
Enterprise Value
602.40M
Revenue
615.00K
Ranking
n/a
PE Ratio
n/a
Stock Price
$4.00
ChartMarket Cap Chart
Since September 8, 2020, Silence Therapeutics's market cap has increased from 538.37M to 674.34M, an increase of 25.26%. That is a compound annual growth rate of 3.79%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 25, 2026 | 673.14M | 134.39% |
| Dec 31, 2025 | 287.18M | -11.59% |
| Dec 31, 2024 | 324.84M | -51.64% |
| Dec 29, 2023 | 671.70M | 22.71% |
| Dec 30, 2022 | 547.37M | -23.44% |
| Dec 31, 2021 | 714.99M | 17.04% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Sep 8, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| CytoDyn | 325.98M |
| Northwest Biotherapeutics | 272.90M |
| Glorywin Entertainment Group | 234.77M |
| BetterLife Pharma | 148.32M |
| Vaxart | 110.62M |
| HST Global | 99.00M |
| NDT Pharmaceuticals | 76.02M |
| Nuo Therapeutics | 60.54M |